The government of the State of São Paulo on Wednesday signed a contract to receive 46 million doses of the potential vaccine against Covid-19 developed by the Chinese Sinovac Biotech that had already been announced as part of the agreement to test the experimental immunizer in Brazil.
According to the president of the Butantan Institute, Dimas Covas, who leads clinical studies with the vaccine, called CoronaVac, in Brazil, the agreement signed this Wednesday also includes the transfer of technology for local production of the vaccine, as it had also been announced.
At a press conference at Palácio dos Bandeirantes, in which the contract was signed with the presence of Covas, Governor João Doria (PSDB) and Sinovac’s world vice president, Weining Meng, Doria said that the 46 million doses will be delivered to the Butantan in December and that there is already an agreement that, until February, another 14 million doses are delivered.
The governor again affirmed that, with the approval of the vaccine registration by the National Health Surveillance Agency (Anvisa), the expectation is to start vaccination from mid-December.
Dimas Covas said that, to date, 7,000 of the 13,000 volunteers participating in clinical trials with the potential vaccine have received the application.
Reuters – This publication including information and data is the intellectual property of Reuters. Its use or your name is expressly prohibited without the prior authorization of Reuters. All rights reserved.